Owner Ambrx, Inc.

Inventors Daniel, Thomas; Sim, Bee-Cheng; Hays Putnam, Anna-Maria A.; Cho, Ho Sung; Litzinger, David; Dimarchi, Richard; Wilson, Troy

Agent FB Rice

Pub. Number AU-B-2009200832

Parent 2005211385

Filing date 3 March 2009

Wipo publication date 19 March 2009

Acceptance publication date 10 May 2012

C07K 14/56 (2006.01) Peptides having more than 20 amino acids

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/61 (2006.01) Peptides having more than 20 amino acids

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

G01N 33/74 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving hormones

A61K 38/00 (2006.01) Medicinal preparations containing peptides